Auto-generated event page

MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance ...

Score 35 low confidence 2 source posts Updated Feb 23, 2026, 9:10 PM UTC

Track This Event Open Event in App More Signal Pages

Cluster sources

Newest source rows first.

MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

GlobeNewswire Public Companies • Feb 23, 2026, 9:05 PM UTC

UroGen Pharma to Report Fourth Quarter and Full-Year 2025 Financial Results on Monday, March 2, 2026

GlobeNewswire Public Companies • Feb 23, 2026, 1:00 PM UTC

Entity focus

Direct link to post

https://pushme.site/signals/118427-maxcyte-to-report-fourth-quarter-and-full-year-2025-financial-results-on?utm_source=signal-118427&utm_medium=social&utm_campaign=signal-pages&utm_content=hero

Quick distribution loop

Step 1

Post this live link in threads where users ask how to monitor this event.

Step 2

Point readers to "Track This Event" for immediate conversion into an alert.

Step 3

Reuse entity keywords from this page for targeted follow-up replies.

Back to signal pages Open query hub